Viral interference with antigen presentation: Trapping TAP

Molecular Immunology

Volumn 55, Issue 2, 2013, Pages 139-142

  Ressing, Maaike E ^a   Luteijn, Rutger D ^a   Horst, Daniëlle ^a   Wiertz, Emmanuel J ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Herpesviruses; Immune evasion; MHC class I; Poxviruses; TAP inhibitors; The transporter associated with antigen processing

Indexed keywords

ABC TRANSPORTER; BNLF2A PROTEIN; CPXV12 PROTEIN; ICP47 PROTEIN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; PEPTIDES AND PROTEINS; PROTEIN INHIBITOR; TRANSPORTER ASSOCIATED WITH ANTIGEN PROCESSING 1; UL49.5 PROTEIN; UNCLASSIFIED DRUG; US6 PROTEIN;

ANTIGEN PRESENTATION; COWPOX VIRUS; CYTOTOXIC T LYMPHOCYTE; HERPES SIMPLEX VIRUS 1; HERPES SIMPLEX VIRUS 2; HUMAN CYTOMEGALOVIRUS; IMMUNOTHERAPY; NONHUMAN; POXVIRUS; PRIORITY JOURNAL; REVIEW; VIRUS GENE; VIRUS INTERFERENCE;

ANTIGEN PRESENTATION; ATP-BINDING CASSETTE TRANSPORTERS; COWPOX VIRUS; HERPESVIRIDAE; HUMANS; IMMUNE EVASION; T-LYMPHOCYTES, CYTOTOXIC; VIRAL PROTEINS;

COWPOX VIRUS; HERPESVIRIDAE;

EID: 84875621203     PISSN: 01615890     EISSN: 18729142     Source Type: Journal    
DOI: 10.1016/j.molimm.2012.10.009     Document Type: Review

References (11)

1. Ackerman A.L., Giodini A., Cresswell P. A role for the endoplasmic reticulum protein retrotranslocation machinery during crosspresentation by dendritic cells. Immunity 2006, 25:607-617.
2. Burgdorf S., Scholz C., Kautz A., Tampe R., Kurts C. Spatial and mechanistic separation of cross-presentation and endogenous antigen presentation. Nature Immunology 2008, 9:558-566.
3. Croft N.P., Shannon-Lowe C., Bell A.I., Horst D., Kremmer E., Ressing M.E., Wiertz E.J., Middeldorp J.M., Rowe M., Rickinson A.B., Hislop A.D. Stage-specific inhibition of MHC class I presentation by the Epstein-Barr virus BNLF2a protein during virus lytic cycle. PLoS Pathogens 2009, 5:e1000490.
4. Hansen S.G., Powers C.J., Richards R., Ventura A.B., Ford J.C., Siess D., Axthelm M.K., Nelson J.A., Jarvis M.A., Picker L.J., Fruh K. Evasion of CD8+ T cells is critical for superinfection by cytomegalovirus. Science 2010, 328:102-106.
5. Horst D., Verweij M.C., Davison A.J., Ressing M.E., Wiertz E.J. Viral evasion of T cell immunity: ancient mechanisms offering new applications. Current Opinion in Immunology 2011, 23:96-103.
6. Jochum S., Ruiss R., Moosmann A., Hammerschmidt W., Zeidler R. RNAs in Epstein-Barr virions control early steps of infection. Proceedings of the National Academy of Sciences of the United States of America 2012, 109:E1396-E1404.
7. Parcej D., Tampe R. ABC proteins in antigen translocation and viral inhibition. Nature Chemical Biology 2010, 6:572-580.
8. Raafat N., Sadowski-Cron C., Mengus C., Heberer M., Spagnoli G.C., Zajac P. Preventing vaccinia virus class-I epitopes presentation by HSV-ICP47 enhances the immunogenicity of a TAP-independent cancer vaccine epitope. International Journal of Cancer 2012, 131:E659-E669.
9. Seidel U.J., Oliveira C.C., Lampen M.H., Hall T. A novel category of antigens enabling CTL immunity to tumor escape variants: Cinderella antigens. Cancer Immunology, Immunotherapy 2012, 61:119-125.
10. Todo T., Martuza R.L., Rabkin S.D., Johnson P.A. Oncolytic herpes simplex virus vector with enhanced MHC class I presentation and tumor cell killing. Proceedings of the National Academy of Sciences of the United States of America 2001, 98:6396-6401.
11. Wilkinson G.W., Lehner P.J. Jenner's irony: cowpox taps into T cell evasion. Cell Host Microbe 2009, 6:395-397.